http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103599427-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103599427-B |
| titleOfInvention | A kind of Chinese medicine composition for the treatment of non-alcohol fatty liver and preparation method thereof |
| abstract | The invention discloses a kind of Chinese medicine composition for the treatment of non-alcohol fatty liver.It is made up of the raw material of following weight parts: Corydalis thalictrifolia Franch. (Radix Corydalis Thalictrifoliae), Rhizoma Picrorhizae, Radix Notoginseng, Radix Salviae Miltiorrhizae, Radix Puerariae, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Poria, Radix Bupleuri, Radix Angelicae Sinensis, Folium Nelumbinis, Semen Coicis, Semen Benincasae, Rhizoma Phragmitis, Radix Platycodonis, Semen Lepidii (Semen Descurainiae), Folium Eriobotryae, Bulbus Fritillariae Cirrhosae, Fructus Lycii, Semen Cassiae, Rhizoma Alismatis, Semen Persicae and Folium Mori.The present invention is proved by pharmacological testing: Chinese medicine composition of the present invention can antagonism insulin resistant, improve insulin sensitivity, reduce blood fat, inflammation-inhibiting reacts, improve Abnormality of Glycolipid Metabolism, alleviate hepatocyte lipidosis, improve liver function and reduce liver index, thus having obvious therapeutical effect to non-alcohol fatty liver rat. |
| priorityDate | 2013-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.